Gf Fund Management Co. Ltd. Vera Therapeutics, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.62 Trillion
- Q4 2024
A detailed history of Gf Fund Management Co. Ltd. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 1,330 shares of VERA stock, worth $38,011. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,330Holding current value
$38,011% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VERA
# of Institutions
193Shares Held
63.9MCall Options Held
68.1KPut Options Held
88.6K-
Avoro Capital Advisors LLC New York, NY5.61MShares$160 Million3.46% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.38MShares$125 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$95.4 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$84.6 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$84.3 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $773M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...